BioCentury | Jan 4, 2019
Financial News

Months after Hong Kong proposal, Stealth now seeking NASDAQ listing

...listings, with mixed results (see "Hong Kong's First Wave" ). Stealth BioTherapeutics Corp., Newton, Mass. Paul Bonanos elamipretide ophthalmic solution 1%...
BioCentury | Dec 30, 2018
Financial News

Months after Hong Kong proposal, Stealth now seeking NASDAQ listing

...biotechs have conducted Hong Kong listings, with mixed results (see "Hong Kong's First Wave" ). Paul Bonanos elamipretide ophthalmic solution 1%...
BioCentury | Jul 13, 2018
Financial News

Stealth, AOBiome propose Hong Kong offerings

..."HKEX Opportunity Knocking" ). Stealth BioTherapeutics Corp., Newton, Mass. AOBiome Therapeutics Inc., Cambridge, Mass. Jaime De Leon elamipretide ophthalmic solution 1%...
BioCentury | Jun 22, 2018
Financial News

Stealth to start Phase IIb of AMD candidate with $100M financing

...apoptosis. Pivotal Beta's Vincent Cheung will join Stealth's board. Stealth BioTherapeutics Inc., Newton, Mass. Elizabeth S. Eaton elamipretide ophthalmic solution 1%...
BioCentury | Jun 18, 2018
Financial News

Stealth to start Phase IIb of AMD candidate with $100M financing

...promote electron transfer and prevent apoptosis. Pivotal Beta's Vincent Cheung will join Stealth's board. Elizabeth S. Eaton elamipretide ophthalmic solution 1%...
BioCentury | Jun 20, 2016
Clinical News

Elamipretide ophthalmic solution 1%: Phase II started

...in the other or elamipretide in both eyes. Stealth BioTherapeutics Inc. , Newton, Mass. Product: Elamipretide ophthalmic solution 1%...
Items per page:
1 - 6 of 6